Your session is about to expire
← Back to Search
Non-Opioid vs. Opioid Pain Management for Pediatric Pancreatitis (PATIENCE Trial)
PATIENCE Trial Summary
This trial will compare two methods of pain relief for kids with pancreatitis in the emergency room. One group will get the usual care, which often includes opioids, and the other group will get an opioid-sparing method. The trial will help researchers understand how well the new method works and how to design a bigger, better trial.
PATIENCE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPATIENCE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PATIENCE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently admitted to the ICU.I weigh at least 8 kilograms.I am 21 years old or younger.I have had kidney or liver problems in the past.I have a history of substance abuse or I use opioids regularly.I am allergic to morphine, hydromorphone, aspirin, or NSAIDs.I have a history of unusual bleeding.I was given pain medication through an IV by myself during my emergency visit.I have been diagnosed with acute pancreatitis or a flare-up of chronic pancreatitis.I have had a peptic ulcer in the past.
- Group 1: Experimental Arm - Ketorolac (Opioid-Sparing)
- Group 2: Control Arm - Conventional Treatment/Standard of Hospital Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you provide a synopsis of past research involving Ketorolac?
"At the moment, there are 93 ongoing trials researching Ketorolac with a third of them in Phase 3. Primarily centered around Boston, Massachusetts, 191 individual sites are running clinical tests on this medication."
Are there any open opportunities for participants in this clinical experiment?
"According to the details available on clinicaltrials.gov, this medical investigation is in need of participants; its first posting was on March 15th 2022 and it underwent an update as recently as April 8th 2022."
Has Ketorolac been granted official authorization by the FDA?
"The potential risks associated with Ketorolac are rated a 2, as the current research has not yielded evidence for its efficacy but there is proof of safety."
What types of ailments is Ketorolac commonly prescribed to treat?
"Ketorolac is generally used to remedy miosis disorder, yet it can also be administered for the purpose of intraocular lens replacement, managing neuropathic pain, and supporting certain therapeutic procedures."
How many individuals have opted to participate in this trial?
"That is correct. According to the information on clinicaltrials.gov, this medical trial was initially posted in March 15th 2022 and has recently been updated as of April 8th 2022. As such, it is still open for fresh enrolments with a quota of 50 patients from one site only."
Share this study with friends
Copy Link
Messenger